UB Paderborn / Katalog / Suche / in CDI

Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel

Clinical cancer research, 2018-12, Vol.24 (23), p.5820-5829

2018

Volltextzugriff (PDF)

Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer

Clinical cancer research, 2021-07, Vol.27 (14), p.3896-3904

2021

Volltextzugriff (PDF)

Combining impact of velocity, fear and refuge for the predator–prey dynamics

Journal of biological dynamics, 2023-12, Vol.17 (1), p.2181989-2181989

2023

Volltextzugriff (PDF)

Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer

NPJ breast cancer, 2022-07, Vol.8 (1), p.80-80, Article 80

2022

Volltextzugriff (PDF)

An eco‐epidemiological predator–prey model where predators distinguish between susceptible and infected prey

Mathematical methods in the applied sciences, 2017-01, Vol.40 (1), p.146-166

2017

Volltextzugriff (PDF)

ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease

NPJ breast cancer, 2023-03, Vol.9 (1), p.10-10, Article 10

2023

Volltextzugriff (PDF)

Predator-prey harvesting model with fatal disease in prey

Mathematical methods in the applied sciences, 2016-07, Vol.39 (10), p.2647-2658

2016

Volltextzugriff (PDF)

Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions

Annals of surgical oncology, 2018-10, Vol.25 (10), p.2948-2952

2018

Volltextzugriff (PDF)

Eco-epidemiological model with fatal disease in the prey

Nonlinear analysis: real world applications, 2020-06, Vol.53, p.103072, Article 103072

2020

Volltextzugriff (PDF)

Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial

JAMA oncology, 2020-09, Vol.6 (9), p.1355

2020

Volltextzugriff (PDF)

Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy

Clinical cancer research, 2024-05, Vol.30 (10), p.2160

2024

Volltextzugriff (PDF)

Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial

Breast cancer research and treatment, 2017-11, Vol.166 (2), p.491-500

2017

Volltextzugriff (PDF)

Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer

Breast cancer research and treatment, 2010-01, Vol.119 (1), p.111-118

2010

Volltextzugriff (PDF)

Cognitive functioning and quality of life following chemotherapy in pre- and peri-menopausal women with breast cancer

Supportive care in cancer, 2018-02, Vol.26 (2), p.575-583

2018

Volltextzugriff (PDF)

Prospective longitudinal study of kinetics of humoral response to one, two, or three doses of SARS-CoV-2 vaccine in hematopoietic cell transplant recipients

Bone marrow transplantation (Basingstoke), 2022-06, Vol.57 (6), p.1013-1016

2022

Volltextzugriff (PDF)

Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer: NeoPACT Phase 2 Clinical Trial

JAMA oncology, 2024-02, Vol.10 (2), p.227

2024

Volltextzugriff (PDF)

Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial

JAMA oncology, 2021-11, Vol.7 (11), p.1654

2021

Volltextzugriff (PDF)

Long term dynamics in a mathematical model of HIV-1 infection with delay in different variants of the basic drug therapy model

Nonlinear analysis: real world applications, 2013-06, Vol.14 (3), p.1621-1633

2013

Volltextzugriff (PDF)

Ki-67 Expression in Benign Breast Ductal Cells Obtained by Random Periareolar Fine Needle Aspiration

Cancer epidemiology, biomarkers & prevention, 2005-04, Vol.14 (4), p.786-789

2005

Volltextzugriff (PDF)

Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer

NPJ breast cancer, 2022-12, Vol.8 (1), p.128-128, Article 128

2022

Volltextzugriff (PDF)

Musculoskeletal Adverse Events Associated with Adjuvant Aromatase Inhibitors

Journal of oncology, 2010-01, Vol.2010, p.1-8

2010

Volltextzugriff (PDF)

Impact of neoadjuvant chemotherapy on axillary nodal involvement in patients with clinically node negative triple negative breast cancer

Journal of surgical oncology, 2015-02, Vol.111 (2), p.198-202

2015

Volltextzugriff (PDF)

Serial single-cell genomics reveals convergent subclonal evolution of resistance as early-stage breast cancer patients progress on endocrine plus CDK4/6 therapy

Nature cancer, 2021-06, Vol.2 (6), p.658

2021

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel

Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer

Combining impact of velocity, fear and refuge for the predator–prey dynamics

Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer

An eco‐epidemiological predator–prey model where predators distinguish between susceptible and infected prey

ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease

Predator-prey harvesting model with fatal disease in prey

Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions

Eco-epidemiological model with fatal disease in the prey

Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial

Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy

Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial

Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer

Cognitive functioning and quality of life following chemotherapy in pre- and peri-menopausal women with breast cancer

Prospective longitudinal study of kinetics of humoral response to one, two, or three doses of SARS-CoV-2 vaccine in hematopoietic cell transplant recipients

Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer: NeoPACT Phase 2 Clinical Trial

Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial

Long term dynamics in a mathematical model of HIV-1 infection with delay in different variants of the basic drug therapy model

Ki-67 Expression in Benign Breast Ductal Cells Obtained by Random Periareolar Fine Needle Aspiration

Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant

Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer

Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer

Musculoskeletal Adverse Events Associated with Adjuvant Aromatase Inhibitors

Impact of neoadjuvant chemotherapy on axillary nodal involvement in patients with clinically node negative triple negative breast cancer

Serial single-cell genomics reveals convergent subclonal evolution of resistance as early-stage breast cancer patients progress on endocrine plus CDK4/6 therapy

Suchergebnisse filtern